Showing results (11-20 of 345) with videos related to
Sort By:
Pageof 35
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Development of a Synthetic Heparin Pentasaccharide: FondaparinuxJeanine M Walenga, Jawed Fareed, Walter P Jeske, et al.Hematology/Oncology Clinics of North America|January 11, 2005
Development of generic low molecular weight heparins: a perspectiveJawed Fareed, Wendy Leong, Debra A Hoppensteadt, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 8, 2011
Functionality of fondaparinux (pentasaccharide) depends on clinical antithrombin levelsWalter P Jeske, Jeanine M Walenga, Meyer M Samama, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 9, 2006
Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysisJyothi Maddineni, Walter P Jeske, Francis Baltasar, et al.Expert Opinion on Investigational Drugs|February 28, 2002
Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agentJeanine M Walenga, Walter P Jeske, M Michel Samama, et al.Seminars in Thrombosis and Hemostasis|January 5, 2005
Generic low-molecular-weight heparins: some practical considerationsJawed Fareed, Wendy L Leong, Debra A Hoppensteadt, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 24, 2012
Comparative studies on branded enoxaparin and a US generic version of enoxaparinJeanine M Walenga, Walter P Jeske, Debra Hoppensteadt, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 9, 2006
Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implicationsJyothi Maddineni, Jeanine M Walenga, Walter P Jeske, et al.Seminars in Thrombosis and Hemostasis|April 9, 2008
Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparinsWalter P Jeske, Jeanine M Walenga, Debra A Hoppensteadt, et al.Current Pharmaceutical Design|May 17, 2007
Heparin oligosaccharides as potential therapeutic agents in senile dementiaQing Ma, Umberto Cornelli, Israel Hanin, et al.Pageof 35